Jonathan Digby‐Bell

1.7k total citations
17 papers, 510 citations indexed

About

Jonathan Digby‐Bell is a scholar working on Epidemiology, Genetics and Infectious Diseases. According to data from OpenAlex, Jonathan Digby‐Bell has authored 17 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Genetics and 4 papers in Infectious Diseases. Recurrent topics in Jonathan Digby‐Bell's work include Inflammatory Bowel Disease (7 papers), Microscopic Colitis (7 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). Jonathan Digby‐Bell is often cited by papers focused on Inflammatory Bowel Disease (7 papers), Microscopic Colitis (7 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). Jonathan Digby‐Bell collaborates with scholars based in United Kingdom, Italy and Canada. Jonathan Digby‐Bell's co-authors include Nick Powell, Giovanni Monteleone, Raja Atreya, Jacqueline D. Shields, Rowan Pritchard‐Jones, Rosey Mushens, Marina Ziche, Rachel M. Perrin, David Gillatt and Jeanette Woolard and has published in prestigious journals such as Gastroenterology, Cancer Research and Gut.

In The Last Decade

Jonathan Digby‐Bell

13 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Digby‐Bell United Kingdom 5 331 97 93 76 65 17 510
Soo Hyun Seo South Korea 14 241 0.7× 42 0.4× 81 0.9× 81 1.1× 85 1.3× 45 496
Chie Kobayashi Japan 13 251 0.8× 59 0.6× 280 3.0× 96 1.3× 57 0.9× 45 665
Anna Serra Italy 21 475 1.4× 136 1.4× 55 0.6× 73 1.0× 93 1.4× 64 1.2k
Vito Alessandro Lasorsa Italy 14 286 0.9× 113 1.2× 230 2.5× 50 0.7× 27 0.4× 36 546
Yoko Hasumi Japan 14 242 0.7× 133 1.4× 76 0.8× 90 1.2× 41 0.6× 29 521
Samsiddhi Bhattacharjee India 10 406 1.2× 116 1.2× 238 2.6× 232 3.1× 36 0.6× 34 730
Andrew Bantly United States 13 294 0.9× 146 1.5× 47 0.5× 46 0.6× 33 0.5× 19 538
Hui Won Jang South Korea 12 80 0.2× 146 1.5× 48 0.5× 36 0.5× 108 1.7× 23 426
Brett V. Johnson Australia 12 366 1.1× 83 0.9× 55 0.6× 95 1.3× 23 0.4× 15 585

Countries citing papers authored by Jonathan Digby‐Bell

Since Specialization
Citations

This map shows the geographic impact of Jonathan Digby‐Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Digby‐Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Digby‐Bell more than expected).

Fields of papers citing papers by Jonathan Digby‐Bell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Digby‐Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Digby‐Bell. The network helps show where Jonathan Digby‐Bell may publish in the future.

Co-authorship network of co-authors of Jonathan Digby‐Bell

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Digby‐Bell. A scholar is included among the top collaborators of Jonathan Digby‐Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Digby‐Bell. Jonathan Digby‐Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Digby‐Bell, Jonathan, et al.. (2025). P0356 A case of pulmonary nodules in Ulcerative Colitis and primary sclerosing cholangitis: is it drug or disease?. Journal of Crohn s and Colitis. 19(Supplement_1). i826–i826.
2.
3.
Ardalan, Zaid, Danny Con, Sujievvan Chandran, et al.. (2021). The Reliability and Accuracy of Endoscopic Items and Scores Used in the Assessment of the Ileoanal Pouch and Cuff. Journal of Crohn s and Colitis. 16(1). 18–26. 4 indexed citations
4.
Digby‐Bell, Jonathan, Raja Atreya, Giovanni Monteleone, & Nick Powell. (2019). Interrogating host immunity to predict treatment response in inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology. 17(1). 9–20. 79 indexed citations
5.
Kassam, Zain, Polychronis Pavlidis, Hajir Ibraheim, et al.. (2019). DOP06 Dynamic shifts in the balance of gut homing Treg and Th17 cells play a critical role in ulcerative colitis and may predict response to vedolizumab therapy. Journal of Crohn s and Colitis. 13(Supplement_1). S030–S031. 1 indexed citations
6.
Pavlidis, Polychronis, Anastasia Tsakmaki, Umar Niazi, et al.. (2019). DOP60 The interleukin 22 transcriptional programme is activated in human colonic inflammation and associated to anti-TNFα primary non-response in Crohn’s. Journal of Crohn s and Colitis. 13(Supplement_1). S065–S065. 1 indexed citations
7.
Goldenberg, Simon, Rahul Batra, Ian Beales, et al.. (2018). Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection in Two English Hospitals: A Review. Infectious Diseases and Therapy. 7(1). 71–86. 43 indexed citations
8.
Digby‐Bell, Jonathan, Andrew B. Williams, Peter M. Irving, & Simon Goldenberg. (2018). Successful faecal microbiota transplant for recurrent Clostridium difficile infection delivered by colonoscopy through a diverted ileostomy in a patient with severe perianal Crohn’s disease. BMJ Case Reports. 2018. bcr–2017. 3 indexed citations
9.
Scottà, Cristiano, Polychronis Pavlidis, Zain Kassam, et al.. (2018). PWE-022 Gut-homing TH17 cells are selectively targeted by vedolizumab and may predict clinical response in IBD. A78.2–A79. 2 indexed citations
10.
Digby‐Bell, Jonathan, Kamal Patel, Mohamed Mutalib, Peter M. Irving, & Simon Goldenberg. (2018). OTU-030 Faecal microbiota transplantation for recurrent clostridium difficile infection: real world uk data. A223.1–A223. 1 indexed citations
11.
Dart, Robin, Pierre Vantourout, Adam Laing, et al.. (2018). DOP075 Colonic gamma delta t-cells respond innately to NKG2D ligands and are grossly dysregulated in active inflammatory bowel disease. Journal of Crohn s and Colitis. 12(supplement_1). S081–S081.
12.
Goldberg, Rimma, Mark Samaan, Jonathan Digby‐Bell, et al.. (2017). PTH-114 Dedicated endoscopic ibd surveillance list improves adherence to guidelines. Gut. 66. A262.2–A263.
13.
Digby‐Bell, Jonathan & Sebastian Zeki. (2017). Uvular necrosis following diagnostic gastroscopy. BMJ Case Reports. 2017. bcr–2017. 2 indexed citations
14.
Samaan, Mark, Polychronis Pavlidis, Jonathan Digby‐Bell, et al.. (2017). Golimumab: early experience and medium-term outcomes from two UK tertiary IBD centres. Frontline Gastroenterology. 9(3). 221–231. 9 indexed citations
15.
Warner, Ben, et al.. (2016). Utilisation of anti-TNF levels in a UK tertiary IBD centre. Frontline Gastroenterology. 8(3). 189–195. 3 indexed citations
17.
Woolard, Jeanette, Wenying Wang, Heather S. Bevan, et al.. (2004). VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant. Cancer Research. 64(21). 7822–7835. 360 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026